NCT00257868View on ClinicalTrials.gov

Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery

PHASE3CompletedINTERVENTIONAL

Enrollment

120

Participants

Timeline

Start Date

January 31, 2006

Study Completion Date

July 31, 2007

Conditions

Delirium

Interventions

DRUG

Rivastigmine prevention of delirium

Trial Locations (1)

4031

University Hospital Basel, Basel

Sponsors

Collaborators (1)

All Listed Sponsors

collaborator

Novartis

INDUSTRY

lead

University Hospital, Basel, Switzerland

OTHER

NCT00257868 - Rivastigmine for the Prevention of Postoperative Delirium in Patients Undergoing Cardiac Surgery | Biotech Hunter | Biotech Hunter